Skip to main content

Table 4 Distribution of serious adverse events across randomization groups

From: Early mechanical ventilation in patients with Guillain-Barré syndrome at high risk of respiratory failure: a randomized trial

 

All patients

n = 50

Experimental group

N = 25

Control group

N = 25

p

In hospital death—yesa

3 (6)

1 (4)

2 (8)

1.00

Septic shock—yes

11 (22)

6 (30)

5 (25)

1.00

Acute renal failure—yes

2 (4)

0 (0)

2 (11)

0.22

Acute hepatic failure—yes

3 (6)

1 (5)

2 (10)

1.00

Acute respiratory distress syndrome— yes

13 (26)

7 (35)

6 (35)

1.00

  1. Data are expressed as number (percentage)
  2. aAt 90-days post-randomization, there were four deaths, with one patient who died after being discharge alive from hospital